GSK and Merck to study immunotherapy combo in solid tumours
November 3, 2015Research and Development GSK, Merck, immunooncology, immunotherapy, keytruda, phase I
GSK and Merck will start a Phase I clinical trial in humans to evaluate GSK’s investigational cancer drugs with the …
Pharma R&D hub BioCity appoints new CFO
November 3, 2015Manufacturing and Production, Research and Development, Sales and Marketing BioCity, Paul Oliver
BioCity, the UK bioscience incubator, has appointed Paul Oliver as chief financial officer as it prepares to grow across its …
Sanofi claims $109m impact on revenue following recall
November 3, 2015Manufacturing and Production Sanofi, finance, maufacturing, product recall
As Sanofi recalls its Auvi-Q epinephrine injection for the treatment of severe allergic reactions – after the company found the …
EU plans export waiver for pharma manufacturing
November 3, 2015Manufacturing and Production EGA, European Commission, biologics, biosimilars, generics, manufacturing, supplementary protection certificates
The European Commission plans to bring in an export waiver for supplementary protection certificates, in order to boost pharma industry …
Sanofi and BioNTech in cancer immunotherapy partnership
November 3, 2015Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy
Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …
Mylan appoints a global commercial lead for OTC business
November 3, 2015Manufacturing and Production Mylan, OTC, Ranjan Ray Chaudhuri, over the counter
Mylan has appointed Ranjan Ray Chaudhuri as its new global commercial lead for the company’s over-the-counter (OTC) business. Chaudhuri will …
FDA alleges records cover-up at Chinese Pfizer plant
November 3, 2015Manufacturing and Production FDA, Pfizer, compliance, inspection, manufacturing, production, regulations
The FDA has discovered violations at a Pfizer plant in China, including the use of out-of-date materials and record- keeping …
Featured market report: 3D printing market summary
November 2, 2015Manufacturing and Production 3d printing, manufacturing, medical devices, production
The global 3D printing medical devices market is estimated to grow at a CAGR of 25.3% from 2015 to 2020.The …
Shire to acquire Dyax in $5.9 billion deal
November 2, 2015Manufacturing and Production, Research and Development, Sales and Marketing Dyax, M&A, MA, R&D, Shire, hereditary angioedema, rare disease
Shire has struck a deal to acquire the biotech firm Dyax for $5.9 billion, in order to acquire exclusive rights …
Biopharma firm F-star appoints Dr Neil Brewis as CSO
November 2, 2015Manufacturing and Production, Research and Development F-star, Neil Brewis
F-star, a biopharma company focused on immuno-oncology, has hired Dr Neil Brewis as chief scientific officer. Dr Brewis is a former vice …
Former Deputy Attorney General called in to advise Valeant after fraud allegations
November 2, 2015Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud
Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …
Allergan subsidiary president arrested on kickback charges
November 2, 2015Sales and Marketing Allergan, US District Court, Warner Chilcott, fraud, healthcare fraud
Allergan subsidiary Warner Chilcott will plead guilty to a US felony charge of healthcare fraud, and settle a case of …
European Commission funds €23m project to develop HIV vaccine
November 2, 2015Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020
The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …
Bayer, Regeneron’s Eylea gets additional EU indication
November 2, 2015Research and Development, Sales and Marketing Bayer, Eylea, Regeneron
The European Commission has granted a fifth indication to Bayer and Regeneron’s eye drug Eylea (aflibercept injection), which is now …
Celgene’s Vidaza earns wider approval
November 2, 2015Sales and Marketing Celgene, European Commission, Vidaza, acute myeloid leukaemia, azacitidine, leukaemia
Swiss firm Celgene has been given approval by the European Commission to extend its marketing authorisation for the cancer treatment …
Merck and Selvita form oncology partnership
November 2, 2015Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology
Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …
AbbVie reports 26% rise in Q3 revenues
October 30, 2015Sales and Marketing AbbVie, Humira
AbbVie has announced stronger-than-anticipated Q3 financial results, its revenues increasing 26.2% on the same period last year to $5.944 billion, …
The pharmaceutical ethics of drug-price increases
October 30, 2015Medical Communications, Research and Development Drug pricing, Turing Pharma, ethics
What is an ‘ethical’ price for a drug?Last month Turing Pharmaceuticals, a start-up run by a former hedge-fund manager, raised …
FDA approves new therapy for pancreatic cancer
October 30, 2015Medical Communications, Sales and Marketing FDA, Pancreatic cancer
The FDA has approved drug a pancreatic cancer drug, Onivyde, which has produced significant overall survival rates in an international …
Valeant drops Philidor after prescription fraud row
October 30, 2015Medical Communications, Sales and Marketing Valeant
Valeant has announced that it is ‘severing all ties with Philidor’, the specialty pharmacy at the heart of recent controversy surrounding …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
